| scholarly article | Q13442814 |
| P50 | author | Irene M Lang | Q87931178 |
| P2093 | author name string | Michael Holzer | |
| David Erlinge | |||
| J Gustav Smith | |||
| Olof Gidlöf | |||
| Bernhard Metzler | |||
| Thomas Engstrøm | |||
| Marko Noc | |||
| Sasha Koul | |||
| Peter Clemmensen | |||
| Moman A Mohammad | |||
| Anna Egerstedt | |||
| P2860 | cites work | IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 |
| Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction | Q28271905 | ||
| Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor | Q30747560 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| The role of interleukin-6 in the failing heart | Q34222978 | ||
| Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction | Q34873552 | ||
| Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability | Q35155075 | ||
| The inflammatory response in myocardial injury, repair, and remodelling. | Q35529656 | ||
| Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion | Q36217826 | ||
| Prognostic value of TNF-related apoptosis inducing ligand (TRAIL) in acute coronary syndrome patients | Q36618290 | ||
| Regulation and functions of the IL-10 family of cytokines in inflammation and disease | Q37821924 | ||
| Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
| Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress | Q38816070 | ||
| Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction: A CHILL-MI Substudy | Q38823055 | ||
| The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. | Q38875774 | ||
| Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction. | Q40049103 | ||
| Pentraxin-3 regulates the inflammatory activity of macrophages | Q41683277 | ||
| Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction | Q44245130 | ||
| Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). | Q44669901 | ||
| Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction | Q45789037 | ||
| C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
| Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities | Q47734765 | ||
| Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig. | Q50709360 | ||
| Clinically significant novel biomarkers for prediction of first ever myocardial infarction: the Tromsø Study. | Q51664920 | ||
| Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. | Q52844573 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction | Q57260454 | ||
| Detection of biomarkers using a novel proximity extension assay in patients with ST-elevation myocardial infarction | Q57815710 | ||
| Rapid Endovascular Catheter Core Cooling Combined With Cold Saline as an Adjunct to Percutaneous Coronary Intervention for the Treatment of Acute Myocardial Infarction | Q60302266 | ||
| [Association between serum interleukin 10 level and development of heart failure in acute myocardial infarction patients treated by primary angioplasty] | Q81876342 | ||
| Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling | Q84916626 | ||
| Interleukin-6-dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction | Q85339327 | ||
| Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) | Q91047010 | ||
| Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction | Q91304576 | ||
| The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study | Q92009745 | ||
| ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans | Q92343883 | ||
| Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone | Q92919892 | ||
| Low-Dose Methotrexate for the Prevention of Atherosclerotic Events | Q92980641 | ||
| Colchicine in Patients with Chronic Coronary Disease | Q99632562 | ||
| P433 | issue | 1 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 18663 | |
| P577 | publication date | 2020-10-29 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction | |
| P478 | volume | 10 |
Search more.